Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population

Pharmacogenetics

Volumn 6, Issue 5, 1996, Pages 423-428

  Agúndez, José A G ^a   Olivera, Manuela ^a   Martínez, Carmen ^a   Ladero, José M ^b   Benítez, Julio ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Genotyping; NAT2; Polymorphism

Indexed keywords

ACYLTRANSFERASE; DNA;

ACETYLATOR PHENOTYPE; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE; NORMAL HUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

ACETYLATION; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; POINT MUTATION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SEX FACTORS; SPAIN; VARIATION (GENETICS);

EID: 0029795003     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199610000-00006     Document Type: Article

References (30)

1. Abe M, Deguchi T, Suzuki T. The structure and characteristics of a fourth allele of polymorphic N-acetyltransferase gene found in the Japanese population. Biochem Biophys Res Commun 1993: 191, 811-816.
2. Agúndez JAG, Martínen C, Olivera M, Ledesma MC, Ladero JM, Benítez J. Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population. Clin Pharmacol Ther 1994: 56, 202-209.
3. Agúndez JAG, Ladero JM, Olivera M, Abildúa R, Román JM, Benítez J. Genetic analysis of the arylamine N-acetyltransferase in breast cancer patients. Oncology 1995: 52, 7-11.
4. Agúndez JAG, Menaya JG, Tejeda R, Lago F, Chávez M, Benítez J. Genetic analysis of the NAT2 and CYP2D6 polymorphisms in white patients with non-insulin-dependent diabetes mellitus. Pharmacogenetics 1996: 6, 465-472.
5. Bell DA, Taylor JA, Butler MA, Stephens EA, Wiest J, Brubaker LH, Kadlubar FF, Lucier GV. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 1993: 14, 1689-1692.
6. Bell DA, Stephens EA, Castranio T, Umbach DM, Watson M, Deakin M, Elder J, Hendrickse C, Duncan H, Strange RC. Polyadenilation polymorphism in the acetyltransferase I gene (NAT1) increases risk of colorectal cancer. Cancer Res 1995: 55, 3537-3542.
7. Blum M, Grant DM, McBride OW, Heim M, Meyer UA. Human arylamine N-acetyltransferase genes: isolation, chromosomal localization and functional expression. DNA Cell Biol 1990: 9, 193-203.
8. Blum M, Demierre A, Grant DM, Heim M, Meyer UA. Molecular mechanisms of slow acetylation of drugs and carcinogens in humans. Proc Natl Acad Sci USA 1991: 88, 5237-5241.
9. Bulpitt CJ. Confidence intervals. Lancet 1987: 1, 494-497.
10. Caporaso N, Landi MT, Vineis P. Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. Pharmacogenetics 1991: 1, 4-19.
11. Clark DWJ. Genetically determined variability in acetylation and oxidation. Drugs 1985: 29, 342-375.
12. Colmenero JD, Fernández-Gallardo LC, Agúndez JAG, Sedeño J, Benítez J, Valverde E. Possible implications of doxycycline-rifampin interaction for treatment of brucellosis. Antimicrob Agents Chemother 1994: 38, 2798-2802.
13. Evans DAP. N-Acetyltransferase. In: Kalow W, ed. Pharmacogenetics of drug metabolism. New York: Pergamon Press, 1992; 95-178.
14. Deguchi T. Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver. J Biol Chem 1992: 267, 18140-18147.
15. 341/803) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles. Drug Metab Disp 1994: 22, 371-376.
16. Graf T, Broly F, Hoffmann F, Probst M, Meyer UA, Howald H. Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers. Eur J Clin Pharmacol 1992: 43, 399-403.
17. Grant DM. Molecular genetics of the N-acetyltransferases. Pharmacogenetics 1993: 3, 45-50.
18. Hein DW, Ferguson RJ, Doll MA, Rustan TD, Gray K. Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hum Mol Genet 1994: 3, 729-734.
19. Hickman D, Sim E. N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans. Biochem Pharmacol 1991: 42, 1007-1014.
20. Lin HJ, Han CY, Lin BK, Hardy S. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanic and whites: application to metabolic epidemiology. Am J Hum Genet 1993: 52, 827-834.
21. Lin HJ, Han CY, Lin BK, Hardy S. Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics 1995: 4, 125-134.
22. Martínez C, Agúndez JAG, Olivera M, Martín R, Ladero JM, Benítez J. Lung cancer and mutations at the polymorphic NAT2 gene locus. Pharmacogenetics 1995: 5, 207-214.
23. Mrozikiewicz PM, Drakouilis N, Roots I. Polymorphic arylamine N-acetyltransferase (NAT2) genes in children with insulin-dependent diabetes mellitus. Clin Pharmacol Ther 1994: 56, 626-634.
24. Neitzel HA. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet 1986: 73, 320-332.
25. Neugebauer S, Baba T, Watanabe T, Ishizaki T, Kurokawa K. The N-acetyltransferase (NAT) gene: an early risk marker for diabetic nephropathy in Japanese type 2 diabetic patients? Diabet Med 1994: 11, 783-788.
26. Ohsako S, Deguchi T. Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J Biol Chem 1990: 265, 4630-4634.
27. Risch A, Wallace DM, Bathers S, Sim H. Slow N-acetylation genitype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet 1995: 4, 231-236.
28. Vatsis KP, Martell KJ, Weber WW. Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc Natl Acad Sci USA 1991: 88, 6333-6337.
29. Vatsis KP, Weber WW, Bell DA, Dupret JM, Evans UA, Grant DM, Hein DW, Lin HJ, Meyer UA, Relling MV, Sim E, Suzuki T, Yamazoe Y. Nomenclature for N-acetyltransferases. Pharmacogenetics 1995: 5, 1-17.
30. Vineis P, Bartsch H, Caporaso N, Harrington AM, Kadlubar FF, Landi MT, Malaveille C, Shields PG, Skipper P, Talaska G, Tannenbaum SR. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 1994: 369, 154-156.